Vertex Pharmaceuticals
VRTX | NASDAQ
$553.15
-$5.73 (-1.03%)
At close: Nov 2, 2026, 4:00 PM ET
$553.64
+$0.49 (+0.09%)
After-hours:
Nov 2, 2026, 4:39 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 4.41B | 4.34B | 3.95B | 3.68B | 3.64B | -988.9M | -535.6M | -479.8M | -489.9M | 4.02B | 3.62B | 3.47B | 3.36B | 3.26B | 3.32B | 3.27B | 3.19B | 2.45B | 2.34B | 2.18B | 1.99B | 2.76B |
Depreciation & Amortization | 222.1M | 217.3M | 209.8M | 200.6M | 199.8M | 202.1M | 207.2M | 219.7M | 208.6M | 196M | 181.3M | 160.7M | 155.3M | 151.2M | 148.3M | 143.73M | 138.73M | 132.67M | 125.6M | 121.12M | 116.07M | 111.53M |
Stock-Based Compensation | 689.1M | 686.2M | 685.9M | 696.1M | 685.8M | 672.7M | 698.5M | 739.3M | 685.6M | 650.7M | 581.2M | 484.1M | 488.8M | 483.4M | 491.3M | 498.41M | 465.8M | 456.53M | 441.4M | 419.82M | 416.36M | 428.93M |
Other Working Capital | -166.4M | -139.4M | -364.4M | -45.2M | -95.4M | -366.6M | 52.3M | -210.1M | -252.5M | 277.2M | 92.6M | 662.4M | 676.1M | 846.4M | 715M | 1.05B | 861.73M | 227.36M | 230.4M | -153.77M | -151.57M | 183.26M |
Other Non-Cash Items | 115.1M | 69.2M | 492.4M | 447.4M | 503.9M | 428.5M | 900K | 3.1M | -62.6M | -65.4M | -42.6M | 41.7M | 9.2M | 43.8M | 103.4M | 30.71M | 40.43M | 16.47M | -5.8M | -129.62M | -131.42M | -225.42M |
Deferred Income Tax | -340.4M | -384.5M | -510.8M | -489.7M | -377.1M | -382.1M | -348.8M | -531.4M | -523.6M | -581.4M | -536.5M | -257.4M | -324.2M | -377M | -275.9M | -465.95M | -215.41M | -223.94M | -154.6M | 99.58M | 87.48M | 297.68M |
Change in Working Capital | -798.2M | -685.9M | -1.2B | -811.5M | -803.6M | -912.6M | -514.8M | -793.5M | -762.1M | -275.3M | -265.7M | 482.3M | 374.2M | 512.5M | 340.8M | 566.38M | 394.02M | -154.14M | -105.2M | -547.05M | -359.61M | -15.89M |
Operating Cash Flow | 4.29B | 4.24B | 3.63B | 3.72B | 3.85B | -980.3M | -492.6M | -842.6M | -944M | 3.94B | 3.54B | 4.38B | 4.07B | 4.07B | 4.13B | 4.05B | 4.02B | 2.68B | 2.64B | 2.14B | 2.12B | 3.36B |
Capital Expenditures | -496.8M | -530.3M | -437.6M | -380.8M | -346.7M | -277.7M | -485.4M | -450.9M | -423.8M | -406.7M | -200.4M | -175.9M | -189.5M | -183.2M | -204.7M | -232.9M | -231.1M | -227.7M | -235M | -220.89M | -343.29M | -311.25M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10M | 10M | 87M | 87M | 77M | 77M | -418.24M | -418.24M | -418.24M |
Purchase of Investments | -7.44B | -7.26B | -6.4B | -7.32B | -7.11B | -6.49B | -7.44B | -6.27B | -5.55B | -4.54B | -3.79B | -3.12B | -2.94B | -2.51B | -788.3M | -585.05M | -603.64M | -600.85M | -605.2M | -670.21M | -557.8M | -491.11M |
Sales Maturities Of Investments | 7B | 6.48B | 5.91B | 6.27B | 6.05B | 5.39B | 4.47B | 3.22B | 2.44B | 1.59B | 934.2M | 1.2B | 1.06B | 840.3M | 920M | 483.07M | 520.33M | 510.93M | 499.3M | 928.03M | 757.91M | 795.8M |
Other Investing Acitivies | 58.7M | -19.4M | -24.7M | -39.7M | -306.6M | -325M | -499.7M | -526.8M | -261.8M | -269M | -89M | 16.8M | -278M | -258.1M | -258.1M | -382.9M | -72M | -77M | -77M | 418.24M | 403.24M | 418.24M |
Investing Cash Flow | -882.8M | -1.32B | -945.4M | -1.48B | -1.71B | -1.69B | -3.77B | -3.83B | -3.6B | -3.44B | -3.14B | -2.08B | -2.35B | -2.1B | -321.1M | -630.7M | -299.45M | -317.59M | -340.9M | 36.85M | -158.14M | -6.59M |
Debt Repayment | -2.8M | -4.1M | -5.4M | -5.3M | -9.3M | -21.7M | -33.6M | -44.3M | -50.2M | -47.5M | -44.9M | -43.3M | -81.5M | -83.2M | -85.5M | -77.56M | -39.16M | -28.76M | -24.47M | -28.3M | -25.04M | -33.17M |
Common Stock Repurchased | -2.01B | -1.93B | -2.02B | -2.31B | -1.54B | -1.47B | -1.18B | -908.7M | -718M | -426M | -427.6M | -278.1M | -161.1M | -132.8M | n/a | -368.18M | -1B | -1B | -1.43B | -1.19B | -664.06M | -664.06M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -744.4M | -322.9M | -363.7M | -371.2M | -364.1M | -438.5M | -398.8M | -397.1M | -366.4M | -288.8M | -224.3M | -220.6M | -215.8M | -217.8M | -168.5M | -167.82M | -147.66M | -145.74M | -130.2M | -147.78M | -167.26M | -168.18M |
Financial Cash Flow | -2.2B | -2.12B | -2.26B | -2.58B | -1.81B | -1.82B | -1.49B | -1.22B | -1B | -625M | -562.2M | -402.2M | -297.4M | -267M | -67.7M | -444.14M | -1.04B | -1.05B | -1.48B | -1.27B | -750.98M | -664.51M |
Net Cash Flow | 1.17B | 819.5M | 515.6M | -300.3M | 391M | -4.48B | -5.8B | -5.87B | -5.56B | -126.2M | -139.7M | 1.94B | 1.45B | 1.69B | 3.71B | 2.9B | 2.63B | 1.29B | 811.26M | 919.23M | 1.24B | 2.71B |
Free Cash Flow | 3.8B | 3.71B | 3.19B | 3.34B | 3.5B | -1.26B | -978M | -1.29B | -1.37B | 3.54B | 3.34B | 4.21B | 3.88B | 3.89B | 3.93B | 3.81B | 3.79B | 2.45B | 2.41B | 1.92B | 1.78B | 3.05B |
Adj. Free Cash Flow | 3.11B | 3.02B | 2.51B | 2.64B | 2.81B | -1.93B | -1.68B | -2.03B | -2.05B | 2.89B | 2.76B | 3.72B | 3.39B | 3.41B | 3.43B | 3.32B | 3.32B | 1.99B | 1.97B | 1.5B | 1.36B | 2.62B |
Maintenance CapEx | -238.12M | -262.69M | -230.69M | -161.28M | -132.96M | -99.05M | -263.01M | -263.98M | -264.36M | -220.23M | -32.37M | -15.22M | -3.04M | n/a | n/a | n/a | n/a | n/a | -18.71M | -18.71M | -18.71M | -18.71M |
Growth CapEx | -258.68M | -267.61M | -206.91M | -219.52M | -213.74M | -178.65M | -222.39M | -186.92M | -159.44M | -186.47M | -168.03M | -160.68M | -186.46M | -183.2M | -204.7M | -232.9M | -231.1M | -227.7M | -216.29M | -202.18M | -324.57M | -292.54M |
Owner Earnings | 4.05B | 3.98B | 3.4B | 3.56B | 3.71B | -1.08B | -755.61M | -1.11B | -1.21B | 3.72B | 3.5B | 4.37B | 4.07B | 4.07B | 4.13B | 4.05B | 4.02B | 2.68B | 2.62B | 2.12B | 2.1B | 3.34B |
Add to Watchlist
Select watchlists to add or remove VRTX